* Instil Bio Inc TIL.OQ reported a quarterly adjusted loss
of 44
cents per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for a loss of 15
cents per share.
* Reported revenue was zero; analysts expected zero.
* Instil Bio Inc's reported EPS for the quarter was a loss
of 44
cents.
* The mean earnings estimate of analysts had risen by
about 53% in
the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Instil Bio Inc shares had fallen by 7.2% this quarter and
lost 2.7% so far this year.
* The company reported a quarterly loss of $57.07 million.
* Wall Street's median 12-month price target for Instil Bio
Inc is
$5.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data May
15 at 01:32 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 -0.15 -0.44 Missed
Dec. 31 2022 -0.41 -0.24 Beat
Sep. 30 2022 -0.44 -0.43 Beat
Jun. 30 2022 -0.41 -0.46 Missed